| 1α,25(OH)2D3 | 1 alpha,25-dihydroxyvitamin D3 |
| 1α-hydroxylase | 1 alpha-hydroxylase |
| 25(OH)D3 | 25-hydroxyvitamin D3 |
| ANOVA | Analysis of variance |
| BLCA | Bladder urothelial carcinoma |
| CAKUT | Congenital anomalies of the kidney and urinary tract |
| CI | confidence interval |
| CYP24A1 | Cytochrome P450 family 24 subfamily A member 1 (vitamin D 24-hydroxylase gene) |
| CYP27B1 | Cytochrome P450 family 27 subfamily B member 1 (25-hydroxyvitamin D 1α-hydroxylase gene) |
| DAPI | 4′,6-diamidino-2-phenylindole |
| dct | Distal convoluted tubule |
| FDR | false discovery rate |
| FFPE | Formalin-fixed paraffin-embedded |
| FGF23 | Fibroblast growth factor 23 |
| GTEx | Genotype-Tissue Expression project |
| H&E | Hematoxylin and eosin staining |
| HSD | Honestly significant difference |
| KICH | Kidney chromophobe carcinoma |
| KIRC | Kidney renal clear cell carcinoma |
| KIRP | Kidney renal papillary cell carcinoma |
| MET | Mesenchymal-to-epithelial transition |
| NR | Nuclear receptor |
| NR1I1 | Nuclear receptor subfamily 1 group I member 1 (alternative name for VDR) |
| PBS | Phosphate-buffered saline |
| pct | Proximal convoluted tubule |
| PTH | Parathyroid hormone |
| qPCR | Quantitative Polymerase Chain Reaction |
| RCC | Renal cell carcinoma |
| RNA | Ribonucleic acid |
| SD | Standard deviation |
| STN | Solid tissue normal |
| TCGA | The Cancer Genome Atlas |
| TPM | Transcripts per million |
| ub | Ureteric bud |
| VDR | Vitamin D receptor |